Latest Breaking News On - Contingent value rights - Page 1 : comparemela.com

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Kelleher-dan-moore
Kevin-moran
Exchange-commission
Vanda-pharmaceuticals-inc
Prnewswire-vanda-pharmaceuticals-inc
Company-board-of-directors-the
Future-pak
Contingent-value-rights
Note-regarding-forward-looking
Financial-condition

Pineapple Energy Reports First Quarter 2024 Financial Results

Pineapple Energy Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Long-island
Hawaii
Kyle-udseth
Eric-ingvaldson
Nasdaq
Pineapple-energy
Hawaii-energy-connection
Pineapple-energy-inc
Exchange-commission
First-quarter

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Jack-kelleher-dan-moore
Kevin-moran
Vanda-pharmaceuticals-inc
Company-nasdaq
Prnewswire-vanda-pharmaceuticals-inc
Future-pak
Contingent-value-rights
Vanda-pharmaceuticals
Corporate-contact
Vice-president

Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash

Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Michigan
United-states
Vanda-pharmaceuticals
Moelis-company
Mackenzie-partners-inc
Pak-increases-bid
Contingent-value-rights
Future-pak
Tina-guilder
Prescription-drug-user-fee-act
Revised-proposal